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ABSTRACT 
The patient presenting with gait disturbance, cognitive decline, or urinary incontinence represents a common cli-
nical dilemma for the practicing neurologist and neurosurgeon. Although these symptoms are suggestive of 
normal pressure hydrocephalus (NPH), they are not specific to the diagnosis and commonly occur in neuro-
degenerative conditions or nonspecifically in advanced age. A lumbar peritoneal (LP) shunt is a technique of 
cerebrospinal fluid (CSF) diversion from the lumbar thecal sac to the peritoneal cavity. It is indicated under a 
large number of conditions such as communicating hydrocephalus, idiopathic intracranial hypertension and 
normal pressure hydrocephalus. 
Objective:  The objective of the study is to determine outcome of lumboperitoneal shunt in patients of normal 
pressure hydrocephalus. 
Study Design:  Case series study. 
Place and Duration of Study:  This study was conducted from December 19, 2012 to June 18, 2013 in the 
department of neurosurgery, Bahawal Victoria Hospital Bahawalpur. 
Subject and Methods:  96 patients of normal pressure hydrocephalus, admitted in neurosurgery ward BVH 
Bahawalpur were included in the study. LP shunt procedure was done under general anesthesia. 3 weeks after 
operation complete clinical examination, urodynamic study and CT scan brain was done to see outcome of LP 
shunt. 
Results:  Total 96 patients were included in our study. The mean age of patients was 67.43 years with standard 
deviation of 5.395 years. Out of 96 patients, 47 (48.96%) were female and 49 (51.04%) patients were male. Out of 
96 patients, 81 (84.38%) patients showed improved gait and 15 (15.62%) patients showed no improvement. Out 
of 96 patients, 49 patients showed improvement in incontinence while 47 patients showed no improvement. Out of 
96 patients, 53 patients showed improvement in memory while 43 patients showed no improvement in memory. 
Conclusion:  Lumboperitoneal shunt placement is a safe and effective shunting for normal pressure hydro-
cephalus, resulting in significant symptomatic improvement with a low risk of over-drainage. 
Keywords:  Lumboperitoneal shunt, normal pressure hydrocephalus, outcome. 
 
INTRODUCTION 
The patient presenting with gait disturbance, cognitive 
decline, or urinary incontinence represents a common 
clinical dilemma for the practicing neurologist and 
neurosurgeon. The diagnostic uncertainty in these pati-
ents is particularly problematic, given the invasive nat-
ure of treatment for NPH.
1
 
 It was our clinical impression that many of these
patients were ultimately not thought to have NPH, 
often because alternate diagnoses better explain their 
symptoms.
2
 
 A lumbar peritoneal (LP) shunt is a technique of 
cerebrospinal fluid (CSF) diversion from the lumbar 
thecal sac to the peritoneal cavity. It is indicated under 
a large number of conditions such as communicating 
hydrocephalus, idiopathic intracranial hypertension, 
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normal pressure hydrocephalus, spinal and cranial CSF 
leaks, pseudomeningoceles, slit ventricle syndrome, 
growing skull fractures which are difficult to treat by 
conventional methods (when dural defect extends deep 
in the cranial base or across venous sinuses and in 
recurrent cases after conventional surgery), raised 
intracranial pressure following chronic meningitis, 
persistent bulging of craniotomy site after operations 
for intracranial tumors or head trauma, syringomyelia 
and failed endoscopic third ventriculostomy with a 
patent stoma. In spite of the large number of indicat-
ions of this shunt and being reasonably good, safe, and 
effective, very few reports about the LP shunt exist in 
the literature.
3
 
 It has an advantage over the VP shunt of being 
completely extracranial and can be used under condi-
tions other than hydrocephalus when the ventricles are 
normal sized.
4
 
 Symptoms of NPH can also resemble those of 
other conditions affecting the elderly. For example, the 
cognitive deficits of NPH can resemble those associ-
ated with early Alzheimer’s, and the gait disturbances 
of NPH can look similar to those of Parkinson’s. More 
publications are required to establish its usefulness in 
the treatment of wide variety of indications. This arti-
cle is aimed to review indications, complications, resu-
lts, and comparison of the LP shunt with the com-
monly practiced ventriculoperitoneal (VP) shunt.
5
 
 
Material and method 
Study Design:  
Case series study. 
 
Duration 
This study was conducted from December 19, 2012 to 
June 18, 2013. 
 
Setting 
Neurosurgery ward, Bahawal Victoria Hospital Baha-
walpur. 
 
Inclusion Criteria 
 Age 60 – 80 years and both gender. 
 Hydrocephalus diagnosed on CT scan brain by 
measuring Evan’s ratio more than (0.3) and peri-
ventricular edema. 
 Urine incontinence diagnosed by detrusor muscle 
over activity on urodynamic study. 
 Duration of symptoms less than 6 moths. 
Exclusion 
 Systemic problem deferring operation (uncon-
trolled diabetes, uremia, hepatic failure, recent 
myocardial infarction). 
 Hydrocephalus of other etiology like post infec-
tion. 
 Gait disturbance due to other disorder of spine or 
joints and urine incontinence due to other disor-
ders of urogenital disorders tract. 
 
Data Analysis 
Data was entered and analyzed into statistical pac-
kages for social sciences (SPSS – 14). Frequency and 
percentages was computed for gender, improvement in 
dementia, gait disturbance, urinary incontinence. Mean 
and standard deviation was computed for quantitative 
variables like age and duration of symptoms. 
 The age, gender was stratified to see the effect of 
those on outcomes through chi-square test. P value less 
than 0.05 was taken as significant. 
 
RESULTS 
Total 96 patients were included in our study. The 
mean age of patients was 67.43 years with standard 
deviation of 5.395 years. Minimum age of patients was 
60 years. Maximum age of patients was 80 years, ran-
ge of age of patients was 20 years, median age of pati-
ents was 67 years and mode age of patients was 62 
years. 
 Out of 96 patients, 47 (48.96%) were female and 
49 (51.04%) patients were male .45 patients were in 
60 – 66 years, 38 patients were in 67 – 74 years of age 
group and 13 patients were in 75 – 80 years of age 
group. Out of 96 patients, 81 (84.38%) patients sho-
wed improved gait and 15 (15.62%) patients showed 
no improvement .43 male patients showed improve-
ment in gait and 6 male patients showed no improve-
ment in gait while 38 female patients showed impro-
ved gait and 9 female patients showed no improve-
ment in gait with insignificant p value of 0.352 .37 
patients in 60 – 66 years of age group showed impro-
vement in gait while 8 patients showed no improve-
ment in gait, 31 patients in 67 – 74 years of age group 
showed improvement in gait while 7 patients showed 
no improvement in gait and 13 patients in 75 – 80 
years of age group showed improvement with insigni-
ficant p value 0.248. 
 Out of 96 patients, 49 patients showed improve-
ment in incontinence while 47 patients showed no 
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improvement. 31 patients in 60 – 66 years of age gro-
up showed improvement in incontinence while 14 
patients showed no improvement in incontinence, 13 
patients in 67 – 74 years of age group showed impro-
vement in incontinence while 25 patients showed no 
improvement in incontinence and 5 patients in 75 – 80 
years of age group showed improvement in inconti-
nence while 8 patients showed no improvement in 
incontinence with significant p value 0.004. 29 male 
patients showed improvement in incontinence and 20 
male patients showed no improvement in incontinence 
while 20 female patients showed improvement in 
incontinence and 27 female patients showed no impro-
vement in incontinence with insignificant p value of 
0.103. 
 
 
 
 Out of 96 patients, 53 patients showed improve-
ment in memory while 43 patients showed no impro-
vement in memory. 25 male patients showed improve-
ment in memory and 24 male patients showed no 
improvement in memory while 28 female patients 
showed improvement in memory and 19 female pati-
ents showed no improvement in memory with insigni-
ficant p value of 0.339. 34 patients in 60 – 66 years of 
age group showed improvement in memory while 11 
patients showed no improvement in memory, 13 
patients in 67 – 74 years of age group showed impro-
vement in memory while 25 patients showed no imp-
rovement in memory and 6 patients in 75 – 80 years of 
age group showed improvement in memory while 7 
patients showed no improvement in memory with 
significant p value 0.001. 
 
DISCUSSION 
Ventriculoperitoneal shunt placement was the standard 
of care for idiopathic normal pressure hydrocephalus 
(NPH). Studies have reported shunt complication rates 
up to 38%, with subdural hemorrhage rates as high as 
10%. Lumboperitoneal (LP) shunts are an alternative 
for cerebrospinal fluid (CSF) diversion that avoids 
direct cerebral injury and may reduce the risk of over-
drainage. Lumboperitoneal shunts have long been used 
in the treatment of benign intracranial hypertension, 
postoperative pseudomeningocele, CSF leak and com-
municating hydrocephalus. Although they can provide 
a rapid and effective resolution of the symptoms there 
are major disadvantages associated with their use.
6
 
 Although cerebrospinal fluid shunting brings abo-
ut the complete alleviation of NPH symptoms in some 
patients, it is more often the case that symptoms are 
only partially alleviated. In addition, the benefits of 
shunt treatment may persist for only a short period of 
time, partially as a result of the overall comorbidity of 
NPH patients. In light of this, the question has been 
raised as to whether or not cerebrospinal fluid shunting 
is worthwhile for all patients. Answering this question 
requires the development of reliable measures to pre-
dict the probability and the extent of clinical improve-
ment with a shunt versus more conservative treat-
ments.
7
 
 In our study 84.38% patients showed improved 
gait, 51.04% patients showed improvement in con-
tinence, 55.21% patients showed improvement in 
memory and 66.67% patients showed decrease in 
Evan’s ratio. In our series, responses to lumboperito-
neal shunting were quite promising. These results were 
comparable to the other studies done in different parts 
of world. 
 In a study conducted by Bloch O et al
8
 showed 
that all 33 (100%) patients had pre-operative gait dys-
function, 28 (85%) had incontinence, and 20 (61%) 
had memory deficits. Mean follow-up time was 19 
months. Following shunt placement, 33/33 (100%) 
patients demonstrated improved gait, 13/28 (46%) had 
improvement in incontinence, and 11/20 (55%) had 
improvement in memory. Shunt failures requiring revi-
sion occurred in nine patients (27%), with an average 
time to failure of 11 months. Infections occurred in 
two patients (6%). There were no neurologic compli-
cations, including no hemorrhages. 
 In another study conducted by McGirt MJ et al
9
 
showed that one hundred thirty – two patients under-
went 179 shunt surgeries. Forty-four (33%), 79 (60%), 
and 99 (75%) patients demonstrated objective impro-
vement 3, 6, and 24 months after shunt surgery, respe-
ctively. Gait improved first in 88 (93%) patients. De-
mentia and urinary incontinence were twofold less 
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likely to improve. Radiological evidence of corpus cal-
losum distension, gait impairment as the primary sym-
ptom, and shorter duration of NPH symptoms predic-
ted improvement. Duration of symptoms and gait as 
the primary symptom were independent predictors by 
multivariate analysis. 
 In the study by Vanneste and colleagues
10
 demon-
strated an overall improvement of 58% after shunt 
insertion. Data from other studies have shown that 
favorable responses to shunt placement based on cli-
nical criteria alone ranges from 27 to 53%.
11 
 In another study conducted by Klassen BT et al
12
 
showed that the incidence of sustained definite impro-
vements at 3 years after shunting was only 0.36 / 
100,000 / year. Definite gait improvement was docu-
mented in 75% at 3 – 6 months after shunt placement, 
although it dropped to 50% at 1 year and to 33% at 3 
years. Only 1 of 8 patients with cognitive impairment 
and 1 of 6 patients with urinary incontinence had defi-
nite improvement in these symptoms at 3 years. No 
patient with moderate to severe postural instability 
experienced sustained definite improvement in any 
symptom. Complications occurred in 33% of patients 
including one perioperative death. 
 A study conducted by Mori K
13
 showed that 120 
patients were identified as having idiopathic NPH and 
these patients underwent placement of shunts. Lumbo-
peritoneal shunt with a programmable valve was used 
in two thirds of the patients. At the end of 3 months 
(early assessment), there was an 80% overall rate of 
clinical improvement, which dropped to 73.3% of the 
105 patients who could be evaluated at the end of the 
3 – year study. Of the three variables, gait disturbance 
was most improved, both at early and late testing peri-
ods. Shunt complications occurred in 22 (18.3%) of 
the patients. 
 In another study conducted by Pujari S et al
14
 sho-
wed that there was an overall sustained improvement 
among all symptoms. Gait showed the highest mainte-
nance of improvement over baseline (83% at 3 years 
and 87% at the last analyzed follow-up of 7 years), 
cognition showed intermediary improvement (84% 
and 86%, respectively), and urinary incontinence sho-
wed the least improvement (84% and 80%, respec-
tively). Fifty – three percent of patients required shunt 
revisions. Indications for revision included shunt mal-
function (87%), infection (10%) and change of shunt 
configuration (3%). Overall, 74% revisions resulted in 
clinical improvement. In this study the mean duration 
of follow-up was 5.9 ± 2.5 years. 
 In a study conducted by Hebb AO et al
15
 showed
that overall, 59% (range, 24 – 100%) of patients impr-
oved after shunting, and 29% (range, 10 – 100%) of 
patients experienced prolonged improvement. Compli-
cations occurred in 38% (range, 5 – 100%) of patients, 
additional surgery was required in 22% (range, 0 – 
47%) of patients, and there was a 6% (range, 0 – 35%) 
combined rate of permanent neurological deficit and 
death. In this study furthermore it was found that clini-
cal findings suggestive of shunt responsiveness were 
the complete triad (gait disturbance, urinary inconti-
nence, and dementia) with early gait disturbance. Deg-
ree of hydrocephalus was not correlated with clinical 
improvement. Reduction of the subcortical low-blood 
flow area was correlated with improvement in three 
small studies. Clinical response to prolonged cerebro-
spinal fluid drainage predicted shunt outcome. 
 In another study conducted by Woodworth GF 
et al
16
 showed that Improvement in 1, 2, or all 3 NPH 
symptoms was observed in 35 (69%), 28 (55%), and 
11 (22%) patients, respectively, after CSF shunt impla-
ntation by 12 months after surgery. A positive respo-
nse to CSF drainage was found to be an independent 
predictor of shunt responsiveness (relative risk, 0.30; 
95% confidence interval, 0.09 – 0.98; P = 0.05). There 
was no difference in Pcsf wave characteristics between 
the shunt – responsive and –nonresponsive groups, 
regardless of whether symptoms improvement was 
used to define response to shunting. To date, the litera-
ture available on this topic has been marked by dispa-
rate definitions of clinical improvement, varying post-
operative follow-up protocols and periods, and sub-
stantial differences in postoperative management. 
Because specific criteria for defining clinical improve-
ment are seldom reported, conclusions drawn about 
shunt outcome may be subjective. Further obfuscating 
an objective analysis of shunt outcome is the presence 
of comorbid factors. This holds particularly true for 
the long period of shunt treatment, although systematic 
studies of short-term versus long-term prognoses are 
few.
17,18
 
 Although there is no doubt that selected patients 
can make a remarkable and prolonged improvement 
after the placement of a shunt, others may not. For any 
individual patient, an assessment must be made with 
respect to risk – to – benefit ratio. The various factors 
that must be considered include the following. From a 
medical decision-making perspective, the probability 
of shunt responsiveness is a more important parameter 
because the patient and his or her family seek an imp-
rovement in functionality, not only a diagnosis. The 
patient must compare the risks of no treatment against 
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proceeding with the shunt procedure. It is important to 
consider that patients who are likely to improve only 
minimally may receive no practical benefit from treat-
ment. In such cases, the risks of treatment may be too 
high, even though some might consider these patients 
“shunt responders.”19 
 
CONCLUSION 
Lumboperitoneal shunt placement is a safe and effe-
ctive shunting for normal pressure hydrocephalus, 
resulting in significant symptomatic improvement with 
a low risk of over-drainage. It should be considered as 
an option for the treatment of patients with normal pre-
ssure hydrocephalus who demonstrate clinical impro-
vement following lumbar drainage. 
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